Nuzenio

Tradingview Travere Therapeutics

Tradingview Travere Therapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 8 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Travere Therapeutics, Inc. Stock 12‑Month Price Target Raised to $68.36, Implies 22% Upside - TradingViewTradingView · Wed, 05 Aug 2026 21:20:21 GMTTVTX: FILSPARI's record Q2 sales and rapid FSGS launch drive strong growth and future confidence - TradingViewTradingView · Tue, 04 Aug 2026 23:17:05 GMTTVTX: FILSPARI's dual-indication launch drove record revenue and robust growth, with strong pipeline progress - TradingViewTradingView · Tue, 04 Aug 2026 22:16:25 GMTTravere Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Tue, 04 Aug 2026 21:01:40 GMTTravere Therapeutics Q2 product sales rise on FILSPARI demand - TradingViewTradingView · Tue, 04 Aug 2026 20:15:44 GMTTVTX: FILSPARI's rapid sales growth and pipeline expansion drive revenue, offset by higher expenses - TradingViewTradingView · Tue, 04 Aug 2026 20:11:06 GMTTVTX Q2'26 Earnings: EPS estimate is (0.10) USD - TradingViewTradingView · Wed, 29 Jul 2026 07:00:00 GMTTravere Therapeutics, Inc. Revenue Breakdown – NASDAQ:TVTX - TradingViewTradingView · Tue, 28 Jul 2026 22:18:25 GMT

Timeline

Wed, 05 Aug 2026 21:20:21 GMTTravere Therapeutics, Inc. Stock 12‑Month Price Target Raised to $68.36, Implies 22% Upside - TradingView
Tue, 04 Aug 2026 23:17:05 GMTTVTX: FILSPARI's record Q2 sales and rapid FSGS launch drive strong growth and future confidence - TradingView
Tue, 04 Aug 2026 22:16:25 GMTTVTX: FILSPARI's dual-indication launch drove record revenue and robust growth, with strong pipeline progress - TradingView
Tue, 04 Aug 2026 21:01:40 GMTTravere Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Tue, 04 Aug 2026 20:15:44 GMTTravere Therapeutics Q2 product sales rise on FILSPARI demand - TradingView
Tue, 04 Aug 2026 20:11:06 GMTTVTX: FILSPARI's rapid sales growth and pipeline expansion drive revenue, offset by higher expenses - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Travere Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.